Bloomberg Stock Movers
2026-07-27 · Hosted by — · Bloomberg / iHeartMedia
Executive Summary
Bloomberg's Stock Movers report opened the week with Nvidia shares up about 1% in pre-market trading on a Wall Street Journal report that the company is in talks to provide a $250 billion backstop for OpenAI, supporting debt financing for a 10-gigawatt data center project SoftBank is developing in southern Ohio — a project that could ultimately cost more than $500 billion, described as roughly equivalent to New York City's peak summer electricity usage. The guarantee would help OpenAI, which lacks an investment-grade rating (a credit rating signaling low default risk) as an unprofitable company, secure lower borrowing costs; it covers the data center lease and build-out debt but not the Nvidia chips themselves. Broader AI-linked names traded higher on the news, including SK Hynix and SanDisk.
Key Stories & Changes
1. Nvidia in Talks for $250 Billion OpenAI Financing Backstop
Nvidia shares up about 1% in pre-market trading
WSJ reports Nvidia is in talks to provide a $250 billion backstop for OpenAI
The guarantee would help secure a lease on a 10-gigawatt data center project in southern Ohio being developed by SoftBank
Full project could cost more than $500 billion — described as comparable to New York City's peak summer electricity demand
The backstop would help OpenAI raise debt at a lower rate, since it lacks an investment-grade rating as an unprofitable company
Covers the data center lease and build-out debt, but not the Nvidia chips that would go inside
Framed as part of a broader trend: larger, better-rated companies backstopping smaller AI players' financing
Broader AI trade higher on the news: SK Hynix, newly listed and up ~6%; SanDisk up 5%
2. Forte Bioscience Acquired for $2.2 Billion
Forte Bioscience (FBRX) being acquired for approximately $2.2 billion in cash at $77/share
Immunology company developing treatments for vitiligo and celiac disease, potentially applicable to multiple autoimmune conditions
Acquirer looking to broaden its immunology portfolio after relying heavily on a single blockbuster drug
Boards of both companies have approved the deal; expected to close this quarter
3. AstraZeneca Beats on Cancer Drug Strength
ADRs up about 1.5% in U.S. pre-market trading
Higher-than-expected profit driven by blockbuster cancer medicines
Key drugs topped estimates; promising results in an experimental gastric cancer treatment
Offset by a disappointing result in a rare blood disorder treatment
Company reiterated its full-year outlook; also advancing an experimental obesity pill
4. AT&T Opens Books on New Bond Offering
Shares down about 0.5% in pre-market
Opened books on a euro and sterling bond offering of at least $2.2 billion
Timing notable: launching during a typically quiet period for European bond markets
Last publicly syndicated bond raise was over a year ago; tapped U.S. markets in April for about $6 billion
Comes on the back of a strong week: stock surged 10% last week, its second-best week since 2022, driven by strong mobile subscriber additions
5. Trip.com Fined But Shares Rise
Chinese regulators ordered Trip.com to halt antitrust practices, refund hotel operators, and pay a fine of over half a billion dollars
Shares (ADR ticker TCOM) up 4% despite the fine
Company had already ceased the flagged practices in January
Goldman Sachs noted the penalty, while relatively high, should be well covered by the company's liquid holdings
NVDA: Nvidia — +1% (pre-market) — In talks for $250B OpenAI financing backstop tied to $500B+ Ohio data center
FBRX: Forte Bioscience — Near $76.32 (deal price $77) — Acquired for $2.2B in cash by an immunology-focused acquirer
AZ: AstraZeneca — +1.5% (pre-market) — Beat on profit driven by cancer drugs; reiterated full-year outlook
T: AT&T — -0.5% (pre-market) — Opening books on $2.2B+ euro/sterling bond offering after strong earnings week
TCOM: Trip.com — +4% — Fined over $500M by Chinese regulators but shares rise on manageable liquidity impact
Trends Identified
1. Larger, Better-Rated Companies Are Backstopping Smaller AI Players' Debt
Nvidia's reported $250 billion OpenAI backstop exemplifies a broader financing pattern emerging in the AI buildout: companies with stronger balance sheets and credit ratings are increasingly guaranteeing debt for less creditworthy but strategically important AI players, allowing massive infrastructure projects to get financed at lower cost despite the underlying borrower's weak credit profile.
2. AI Infrastructure Projects Reaching Unprecedented Scale
The scale of the SoftBank-developed Ohio data center — a 10-gigawatt project potentially costing more than $500 billion and consuming power comparable to all of New York City at peak summer demand — underscores how individual AI infrastructure projects have grown to a scale that requires novel financing structures like third-party backstops to get built.
3. Corporate Bond Issuance Windows Being Used Opportunistically
AT&T's decision to open books on a new bond offering during a typically quiet European market period, right after a strong earnings-driven stock rally, suggests companies are timing debt issuance to capitalize on positive investor sentiment momentum rather than waiting for conventional issuance windows. ---
Sentiment Analysis
Overall Market Sentiment: Constructive
The session opened with a broadly positive tone, led by AI-linked financing news and several earnings/M&A beats, with markets shrugging off a large regulatory fine against Trip.com.
Risk Factors Highlighted
OpenAI's credit quality: Described explicitly as unprofitable and lacking an investment-grade rating, requiring third-party guarantees to finance debt.
Scale of concentrated AI infrastructure bets: A single project potentially exceeding $500 billion concentrates significant financing and execution risk.
Regulatory risk in China: Trip.com's antitrust fine highlights ongoing regulatory scrutiny of U.S.-listed Chinese companies.
Bond market timing risk: AT&T issuing during a "typically quiet" period could reflect either opportunistic strength or urgency to lock in favorable terms.
This episode was covered in today's [The Market Signal — 2026-07-27](https://marketsignal.beehiiv.com/p/the-market-signal-2026-07-27), a cross-source synthesis of multiple podcast reports.